NRS at the end < 4 | NRS at the end 4–5 | NRS at the end ≥ 6 | |||||||
---|---|---|---|---|---|---|---|---|---|
Variable | Overall (n = 830) [n(%)] | Nalbuphine + Paracetamol (n = 796) [n(%)] | Morphine (n = 34) [n(%)] | Overall (n = 648) [n(%)] | Nalbuphine + Paracetamol (n = 576) [n(%)] | Morphine (n = 72) [n(%)] | Overall (n = 330) [n(%)] | Nalbuphine + Paracetamol (n = 263) [n(%)] | Morphine (n = 67) [n(%)] |
Age in years [mean ± SD] | 55.7 ± 21.3 | 55.4 ± 21. | 59.3 ± 22.7 | 55.5 ± 22.0 | 55.1 ± 22.7 | 59.4 ± 20.2 | 55.8 ± 20.5 | 55.1 ± 20.7 | 58.6 ± 19.4 |
Female sex | 435 (52.4) | 414 (52.0) | 21 (61.7) | 354 (54.6) | 320 (55.6) | 34 (47.2) | 172 (52.1) | 143 (54.4) | 29 (43.3) |
Initial NRS | |||||||||
Mean ± SD | 7.8 ± 1.5 | 7.8 ± 1.5 | 7.8 ± 1.2 | 8.0 ± 1.3 | 7.9 ± 1.3 | 8.4 ± 1.1 | 8.6 ± 1.1 | 8.5 ± 1.2 | 9.1 ± 0.9 |
Median (Q1; Q3) | 8.0 (7.0; 9.0) | 8.0 (7.0; 9.0) | 8.0 (7.0; 8.0) | 8.0 (7.0; 9.0) | 8.0 (8.0; 10.0) | 8.0 (8.0; 9.0) | 9.0 (8.0; 10.0) | 8.0 (8.0; 10.0) | 9.0 (8.0; 10.0) |
NRS at the end of the operation | |||||||||
Mean ± SD | 2.1 ± 1.0 | 2.1 ± 1.0 | 2.4 ± 0.7 | 4.4 ± 0.5 | 4.4 ± 0.5 | 4.5 ± 0.5 | 7.1 ± 1.2 | 7.1 ± 1.2 | 7.1 ± 1.2 |
Median (Q1; Q3) | 2.0 (2.0; 3.0) | 2.0 (2.0; 3.0) | 3.0 (2.0; 3.0) | 4.0 (4.0; 5.0) | 4.0 (4.0; 5.0) | 4.0 (4.0; 5.0) | 7.0 (6.0; 8.0) | 7.0 (6.0; 8.0) | 7.0 (6.0; 8.00 |
NRS reduction | |||||||||
Mean ± SD | 5.7 ± 1.9 | 5.7 ± 1.9 | 5.3 ± 1.3 | 3.6 ± 1.4 | 3.5 ± 1.4 | 3.9 ± 1.1 | 1.5 ± 1.4 | 1.4 ± 1.4 | 2.0 ± 1.0 |
Median (Q1; Q3) | 6.0 (4.0; 7.0) | 6.0 (4.0; 7.0) | 6.0 (5.0; 6.0) | 4.0 (3.0; 4.0) | 4.0 (3.0; 4.0) | 4.0 (3.0; 5.0) | 2.0 (0.0; 2.0) | 1.0 (0.0; 2.0) | 2.0 (1.0; 3.0) |
Dose of pain medication in mg (∑) | |||||||||
Nalbuphine in mg | 8.7 ± 8.2 | 8.7 ± 8.2 | - | 7.7 ± 8.3 | 7.7 ± 8.3 | - | 6.9 ± 9.0 | 6.9 ± 9.0 | - |
Paracetamol in mg | 991.2 ± 83.3 | 991.2 ± 83.3 | - | 988.5 ± 89.4 | 988.5 ± 89.4 | - | 992.8 ± 82.8 | 992.8 ± 82.8 | - |
Morphine in mg | 3.6 ± 2.1 | - | 3.6 ± 2.1 | 4.2 ± 1.8 | - | 4.2 ± 1.8 | 5.4 ± 2.6 | - | 5.4 ± 2.6 |
Complications | |||||||||
Nausea and vomiting | 19 (2.3) | 17 (2.1) | 2 (5.9) | 11 (1.7) | 11 (1.9) | 0 (0.0) | 11 (3.3) | 7 (2.7) | 4 (6.0) |
Reduction of vigilance | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (0.3) | 0 (0.0%) | 1 (1.5) |
Respiratory insufficiency | 1 (0.1) | 0 (0.0) | 1 (2.9) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (0.3) | 0 (0.0) | 1 (1.5) |
Haemodynamic insufficiency | 1 (0.1) | 0 (0.0) | 1 (2.9) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Cause of pain | |||||||||
Traumatic | 345 (41.6) | 337 (42.3) | 8 (23.5) | 276 (42.6) | 264 (45.8) | 12 (16.7) | 138 (41.8) | 109 (41.4) | 29 (43.3) |
Non-traumatic | |||||||||
Musculosceletal | 152 (18.3%) | 151 (19.0%) | 1 (2.9) | 128 (19.7) | 123 (21.3) | 5 (6.9) | 60 (18.2) | 53 (20.1) | 7 (10.4) |
Visceral | 303 (36.5) | 290 (36.4) | 13 (38.2) | 210 (32.4) | 175 (30.4) | 35 (48.6) | 107 (32.4) | 88 (33.5) | 19 (28.4) |
Non-traumatic chest pain | 9 (1.1) | 0 (0.0) | 9 (26.5) | 11 (1.7) | 0 (0.0) | 11 (15.3) | 5 (1.5) | 0 (0.0) | 5 (7.5) |
Cephalgia | 15 (1.8) | 15 (1.9) | 0 (0.0) | 16 (2.5) | 13 (2.3) | 3 (4.2) | 11 (3.3) | 10 (3.8) | 1 (1.5) |
Others | 6 (0.7) | 3 (0.4) | 3 (8.8) | 7 (1.1) | 1 (0.2) | 6 (8.3) | 9 (2.7) | 3 (1.1) | 6 (9.0) |